These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 9870683)

  • 21. Stromal cell-derived factor-1alpha and CXCR4 expression in hemangioblastoma and clear cell-renal cell carcinoma: von Hippel-Lindau loss-of-function induces expression of a ligand and its receptor.
    Zagzag D; Krishnamachary B; Yee H; Okuyama H; Chiriboga L; Ali MA; Melamed J; Semenza GL
    Cancer Res; 2005 Jul; 65(14):6178-88. PubMed ID: 16024619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Quantitative immunohistochemical analysis of matrilysin 1 (MMP-7) in various renal cell carcinoma subtypes.
    Patraki E; Cardillo MR
    Int J Immunopathol Pharmacol; 2007; 20(4):697-705. PubMed ID: 18179742
    [TBL] [Abstract][Full Text] [Related]  

  • 23. LRIG1 and epidermal growth factor receptor in renal cell carcinoma: a quantitative RT--PCR and immunohistochemical analysis.
    Thomasson M; Hedman H; Guo D; Ljungberg B; Henriksson R
    Br J Cancer; 2003 Oct; 89(7):1285-9. PubMed ID: 14520461
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Clear cell renal cell carcinoma: discrimination from other renal cell carcinoma subtypes and oncocytoma at multiphasic multidetector CT.
    Young JR; Margolis D; Sauk S; Pantuck AJ; Sayre J; Raman SS
    Radiology; 2013 May; 267(2):444-53. PubMed ID: 23382290
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of KIT (CD117) in chromophobe renal cell carcinoma and renal oncocytoma.
    Pan CC; Chen PC; Chiang H
    Am J Clin Pathol; 2004 Jun; 121(6):878-83. PubMed ID: 15198361
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Epidermal growth factor family and renal cell carcinoma: expression and prognostic impact.
    Hofmockel G; Riess S; Bassukas ID; Dämmrich J
    Eur Urol; 1997; 31(4):478-84. PubMed ID: 9187911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epidermal growth factor receptor protein expression and genomic alterations in renal cell carcinoma.
    Minner S; Rump D; Tennstedt P; Simon R; Burandt E; Terracciano L; Moch H; Wilczak W; Bokemeyer C; Fisch M; Sauter G; Eichelberg C
    Cancer; 2012 Mar; 118(5):1268-75. PubMed ID: 22161775
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Non-clear cell advanced kidney cancer: is there a gold standard?
    Sánchez P; Calvo E; Durán I
    Anticancer Drugs; 2011 Jan; 22 Suppl 1():S9-14. PubMed ID: 21173605
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Spectrum of epithelial neoplasms in end-stage renal disease: an experience from 66 tumor-bearing kidneys with emphasis on histologic patterns distinct from those in sporadic adult renal neoplasia.
    Tickoo SK; dePeralta-Venturina MN; Harik LR; Worcester HD; Salama ME; Young AN; Moch H; Amin MB
    Am J Surg Pathol; 2006 Feb; 30(2):141-53. PubMed ID: 16434887
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Prognostic and diagnostic implications of epithelial cell adhesion/activating molecule (EpCAM) expression in renal tumours: a retrospective clinicopathological study of 948 cases using tissue microarrays.
    Zimpfer A; Maruschke M; Rehn S; Kundt G; Litzenberger A; Dammert F; Zettl H; Stephan C; Hakenberg OW; Erbersdobler A
    BJU Int; 2014 Aug; 114(2):296-302. PubMed ID: 24215118
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Presence of phosphorylated hepatocyte growth factor receptor/c-Met is associated with tumor progression and survival in patients with conventional renal cell carcinoma.
    Miyata Y; Kanetake H; Kanda S
    Clin Cancer Res; 2006 Aug; 12(16):4876-81. PubMed ID: 16914575
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Papillary renal cell carcinoma with clear cell cytomorphology and chromosomal loss of 3p.
    Füzesi L; Gunawan B; Bergmann F; Tack S; Braun S; Jakse G
    Histopathology; 1999 Aug; 35(2):157-61. PubMed ID: 10460661
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Histone modifications: implications in renal cell carcinoma.
    Ramakrishnan S; Ellis L; Pili R
    Epigenomics; 2013 Aug; 5(4):453-62. PubMed ID: 23895657
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Renal cell carcinoma: dynamic contrast-enhanced MR imaging for differentiation of tumor subtypes--correlation with pathologic findings.
    Sun MR; Ngo L; Genega EM; Atkins MB; Finn ME; Rofsky NM; Pedrosa I
    Radiology; 2009 Mar; 250(3):793-802. PubMed ID: 19244046
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Familial clear cell renal cell carcinoma (FCRC): clinical features and mutation analysis of the VHL, MET, and CUL2 candidate genes.
    Woodward ER; Clifford SC; Astuti D; Affara NA; Maher ER
    J Med Genet; 2000 May; 37(5):348-53. PubMed ID: 10807693
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clear cell papillary renal cell carcinoma and clear cell renal cell carcinoma arising in acquired cystic disease of the kidney: an immunohistochemical and genetic study.
    Kuroda N; Shiotsu T; Kawada C; Shuin T; Hes O; Michal M; Ohe C; Mikami S; Pan CC
    Ann Diagn Pathol; 2011 Aug; 15(4):282-5. PubMed ID: 20952286
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of aquaporin 1 in primary renal tumors: a prognostic indicator for clear-cell renal cell carcinoma.
    Huang Y; Murakami T; Sano F; Kondo K; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Eur Urol; 2009 Oct; 56(4):690-8. PubMed ID: 18930582
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Small (< 4 cm) Renal Mass: Differentiation of Oncocytoma From Renal Cell Carcinoma on Biphasic Contrast-Enhanced CT.
    Sasaguri K; Takahashi N; Gomez-Cardona D; Leng S; Schmit GD; Carter RE; Leibovich BC; Kawashima A
    AJR Am J Roentgenol; 2015 Nov; 205(5):999-1007. PubMed ID: 26496547
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Functional intactness of stimulatory and inhibitory autocrine loops in human renal carcinoma cell lines of the clear cell type.
    Ramp U; Jaquet K; Reinecke P; Schardt C; Friebe U; Nitsch T; Marx N; Gabbert HE; Gerharz CD
    J Urol; 1997 Jun; 157(6):2345-50. PubMed ID: 9146668
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
    Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.